Hemolytic Disease of Newborn

DBCOND0028919Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesHemic and Lymphatic Diseases

Hemolytic Disease of Newborn is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Erythroblastosis foetalis · Hemolytic Disease of the Newborn · Erythroblastosis, Fetal · Hemolytic Disease of the Fetus and Newborn · HDN - Hemolytic Disease of the Newborn
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0007688ICD-10P55SNOMED CT111468003MedDRA10015250UMLSC0014761

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Hemolytic Disease of Newborn share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In